Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. - Wikidata - thesis-toulmin - TriplyDB

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

http://www.wikidata.org/entity/Q30482915

about

The rising challenge of non-AIDS-defining cancers in HIV-infected patients Advances in the understanding of cancer immunotherapy Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells The challenge of AIDS-related malignancies in sub-Saharan Africa.Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.Melanoma epidemiology, biology and prognosis.Is HIV a model of accelerated or accentuated aging?Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007 Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.HIV/AIDS and Colorectal Cancer: A Review in the Era of Antiretrovirals.Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells Cancer in HIV-infected persons from the Caribbean, Central and South America.Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?Raltegravir use in special populations Melanoma in immunosuppressed patients HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer Determination of the underlying cause of death in three multicenter international HIV clinical trials.CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection Immune surveillance and lymphoid malignancy in immunocompromised host.Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?HIV and prostate cancer: a systematic review of the literature.Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.Evolving spectrum and incidence of non-AIDS-defining malignancies.Cutaneous malignancies among HIV-infected persons.Human immunodeficiency virus and cancer. A population of HIV-infected patients at Hospital de Santa Maria and predictors of cancer.

P2860

Q26861496-21C01560-FCF7-4F79-BA54-6DEED1AD6C23 Q27000706-D087B220-F099-446A-87BC-BBF4FB210A1F Q28081273-E40CB26C-F0DC-47ED-86A9-019FD8F39916 Q28548473-F58A58D6-1756-44F1-9A98-11DD3941A9BD Q33523293-CCE323B6-114F-4F0F-984A-14CBDF3BAFBA Q33564397-69EF7AAC-4EEF-4D1C-B474-2237EE7CB714 Q33587716-9949504F-FCE5-45B9-9B8D-2A59405A9D34 Q33698718-0DD4065E-1A1A-4827-A3D2-01905262BD98 Q33792651-95015988-FBDB-4137-9434-01E0F5F55C47 Q33987654-9EF7751C-5297-463A-8D54-827351191C78 Q34158436-09A4F82B-C799-4BF0-91B9-F008EB10D87D Q34348772-D7945EB8-3769-4447-82DB-FBC066063618 Q34481581-B6452E2C-041C-4C67-B399-61E37A6BEAFD Q34612071-D7BB00A9-069B-438D-9ECF-7D94736C17A7 Q34722581-8D314BAB-6F46-41F6-8119-B89231974E8F Q34844389-71C007FE-2556-414B-9332-CC7272642DDC Q34978561-992D1338-99B1-411D-BB0E-6272B2700725 Q35063571-1AC6032E-5CC5-479A-90DB-4F0824D45967 Q35071910-579E249B-37B8-421E-86B3-637B69341EBA Q35233148-E53AB315-0598-4218-B130-F5ECDD9FB41C Q35552875-DCCBE07D-D276-4AA1-9ED6-421E5CA1D296 Q35612742-6F14AB4E-8FBE-43EA-8AE3-205CC7EA34CA Q35634280-C7909B40-A3EA-4883-A210-273D06984F17 Q35801613-61EE512D-34C7-42BC-B245-347B6752799E Q35850380-6FB36BAF-E138-4EF1-A774-C212A0C83345 Q36036666-69336839-0EA3-448C-9D71-62F8119DA97A Q36132370-9F712A9E-1401-4FF4-BD6E-3786BC715CD1 Q36452179-6F68C44E-5421-4277-A7D0-5C0C42734FCD Q36512842-3B137582-7462-4DE8-9C85-37F4AE048AC2 Q36659641-3FA7109C-0C9E-4CD3-8B12-3888B031C605 Q36739701-7D43110E-1C12-4310-A1A3-7CACDAB23374 Q36745251-2AC05577-3DFF-4C5C-A553-3D5BFB56C885 Q36831205-C6EC226F-EE3E-43F0-A548-3EB0305F96BF Q37180845-E5110487-FF15-4789-8109-AFF51A1792EC Q37233212-B72696E3-4EC1-4787-B79E-1D33FFA954F4 Q37246654-26A059A6-CB91-4B26-8911-63940D7D5C26 Q37309589-7882CD61-6F85-45A4-8688-3AFB1D7F05E3 Q37353390-553903A0-DEEB-43C6-8970-0BD1DB16BC53 Q37387284-4D0C9137-91ED-4F18-98DE-2FCB0440E167 Q37441664-8CA0DC79-788E-4517-B2FE-6FD6B600CC37

P2860

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

http://www.wikidata.org/entity/Q30482915

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Incidence and risk factors for ...... cy virus-infected individuals.

@ast

Incidence and risk factors for ...... cy virus-infected individuals.

@en

type

label

Incidence and risk factors for ...... cy virus-infected individuals.

@ast

Incidence and risk factors for ...... cy virus-infected individuals.

@en

prefLabel

Incidence and risk factors for ...... cy virus-infected individuals.

@ast

Incidence and risk factors for ...... cy virus-infected individuals.

@en

P1433

Q30482915-A3620665-4732-41D9-8402-10BE2A62F378

P1476

Q30482915-76E6BE2E-0E9C-4C18-9486-21F326C925FF

P2093

Q30482915-2B627165-9E57-49A4-8734-833A9A398284

Q30482915-492B6485-CA95-4F00-A378-F0DF2CF14B66

Q30482915-4D7F0B5F-DE3C-49FE-9716-6D904B4F9DE6

Q30482915-A51A6C4F-6F6F-45F6-920B-C5C6013404A0

Q30482915-C0B66385-9E6C-4ED2-8B65-A6BBDC8B8AC5

Q30482915-C1BA3B03-DEA7-4A67-8A1D-6898E42C12B7

Q30482915-D07E5C5C-8681-43B1-84A4-A2AC476CA4C2

Q30482915-E7061187-B298-4528-844F-C52DB5434477

Q30482915-F22A1621-1330-4B4B-A6A7-6526E631722D

Q30482915-F6415300-93AB-49FD-B1BE-B149ABB61B65

P304

Q30482915-2192ED36-3865-4A7B-B989-3E811A0A990B

P31

Q30482915-FB478DEA-FAF6-4B53-933B-861D98C85CCB

P356

Q30482915-D06824DB-47F6-4161-884A-51919022CCCA

P407

Q30482915-D31E809C-A34F-42A9-900A-84C43B59BAE5

P433

Q30482915-99854BA2-544F-449A-BCCB-DEF952F151D7

P478

Q30482915-771BB2BF-D21E-4683-8098-732D90AF12D1

P50

Q30482915-9FC751FB-F78D-440F-9BAC-D015D130B654

P577

Q30482915-614C0194-0F81-47C9-9C96-FAF524A2977A

P5875

Q30482915-4234B844-5E41-48C8-985C-1F938C4E23B4

P698

Q30482915-3D29A372-C445-4732-8779-0A35CEC57EE1

P356

P1433

P1476

Incidence and risk factors for ...... cy virus-infected individuals.

@en

P2093

Adam Armstrong

http://www.w3.org/2001/XMLSchema#string

Alina Burgi

http://www.w3.org/2001/XMLSchema#string

David L Blazes

http://www.w3.org/2001/XMLSchema#string

Katherine Spooner

http://www.w3.org/2001/XMLSchema#string

Mark Milazzo

http://www.w3.org/2001/XMLSchema#string

Mark R Wallace

http://www.w3.org/2001/XMLSchema#string

Nancy F Crum

http://www.w3.org/2001/XMLSchema#string

Scott Wegner

http://www.w3.org/2001/XMLSchema#string

Stephanie Brodine

http://www.w3.org/2001/XMLSchema#string

Susan Fraser

http://www.w3.org/2001/XMLSchema#string

P304

1505-1511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.21334

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7656682

http://www.w3.org/2001/XMLSchema#string

P698

16104038

http://www.w3.org/2001/XMLSchema#string